- Capital Cube•21 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closing price.Technical IndicatorsBelow is a quick look at 5 technical indicators for Compugen Ltd.. More studies are available on the Technical Chart.IndicatorSignalClosing Price above/below 50 Day Moving AverageBearishClosing Price above/below 200 Day Moving AverageBullish50 Day Moving Average above/below 200 Day Moving AverageBullishRSI […] (Read more...) The post Compugen Ltd. breached its 50 day moving average in a Bearish Manner : CGEN-US : July 8, 2016 appeared first on CapitalCube.
- Benzinga•last monthCompugen Names Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program IND filing For COM701 Anticipated in 2017
Compugen Ltd. (NASDAQ: CGEN ) announced disclosed COM701 as the lead monoclonal antibody therapeutic candidate for its CGEN-15029 target program. The company made the announcement at the JMP Securities ...
|Bid||6.46 x 500|
|Ask||7.10 x 500|
|52wk Range||4.32 - 7.79|
|Day's Range||6.55 - 6.75|
|Avg Vol (3m)||98,741|
As of 4:00 PM EDT. Market closed.